"abrocitinib" meaning in All languages combined

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "abrocitinib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172",
          "text": "Another JAK1-selective jakinib, abrocitinib, has been evaluated in phase III trials in atopic dermatitis and plaque psoriasis (61, 62), showing efficacy in both diseases. AEs included herpes simplex and herpes zoster infection, appendicitis, pancreatitis, and IBD.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A medication belonging to the class of Janus kinase inhibitors, used for the treatment of atopic dermatitis."
      ],
      "id": "en-abrocitinib-en-noun-c0~ethun",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "medication",
          "medication"
        ],
        [
          "Janus kinase",
          "Janus kinase"
        ],
        [
          "inhibitor",
          "inhibitor"
        ],
        [
          "treatment",
          "treatment"
        ],
        [
          "atopic dermatitis",
          "atopic dermatitis"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A medication belonging to the class of Janus kinase inhibitors, used for the treatment of atopic dermatitis."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "abrocitinib"
}

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "abrocitinib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172",
          "text": "Another JAK1-selective jakinib, abrocitinib, has been evaluated in phase III trials in atopic dermatitis and plaque psoriasis (61, 62), showing efficacy in both diseases. AEs included herpes simplex and herpes zoster infection, appendicitis, pancreatitis, and IBD.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "A medication belonging to the class of Janus kinase inhibitors, used for the treatment of atopic dermatitis."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "medication",
          "medication"
        ],
        [
          "Janus kinase",
          "Janus kinase"
        ],
        [
          "inhibitor",
          "inhibitor"
        ],
        [
          "treatment",
          "treatment"
        ],
        [
          "atopic dermatitis",
          "atopic dermatitis"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A medication belonging to the class of Janus kinase inhibitors, used for the treatment of atopic dermatitis."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "abrocitinib"
}